Neuros Medical, a US-based neurostimulation company, has obtained an investigational device exemption (IDE) clearance from the US Food and Drug Administration (FDA) to initiate a randomized, controlled pivotal clinical trial to evaluate the ...
Tags: Neuros Medical, Altius System
The US Food and Drug Administration (FDA) advisory panel has recommended the expanded indication of Medtronic’s cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D) for the treatment of patients who ...
ISTO Technologies has completed enrollment of its Phase II clinical trial of NuQu, a novel, cell-based therapy for the treatment of pain and disability associated with degenerated spinal discs. The company has completed enrollment of 44 ...
Tags: ISTO Technologies, Back Pain Study
The Israeli Ministry of Health (IMH) has approved Pluristem Therapeutics’ request to start a Phase II trial using its PLacental eXpanded (PLX) cells in the treatment of intermittent claudication (IC). IC is a subset of peripheral ...
Tags: clinical study, Medicine
SuperSonic Imagine, a medical ultrasound company, announced its Aixplorer MultiWave ultrasound system has obtained the US Food and Drug Administration (FDA) approval for the quantification capabilities of its real-time ShearWave ...
Tags: SuperSonic Imagine, Medicine
Scientists from Northwestern University have developed a new intravaginal ring that could help prevent women from immunodeficiency virus. The ring is easily inserted and stays in place for 30 days,delivering a measured amount of the ...
Tags: Immunodeficiency Virus, Medicine
UK-based healthcare services provider United Drug's packaging services have been rebranded as Sharp Packaging Services to enable the organization serve better. Sharp Packaging Services provides clinical and commercial packaging services ...
Tags: United Drug, Packaging Services
Scotland-based eClinicalHealth has launched a new patient-centric cloud-based platform called 'Clinpal' designed to improve patient engagement at every stage of the clinical trial. Typically, recruitment difficulties delay 86% of studies ...
Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
The US Food and Drug Administration (FDA) has approved US-based StemCells’ investigational new drug (IND) application for clinical testing of its HuCNS-SC human neural stem cells as a treatment for spinal cord injury. StemCells is ...
Tags: Spinal Cord Injury, Medicine
Canadian regulatory authority Health Canada has approved Valeant Pharmaceuticals International subsidiary Valeant Canada's new drug submission of Jublia for the treatment of onychomycosis. Jublia is designated for the treatment of mild to ...
Tags: Fungal Drug, Medicine
NovaDigm Therapeutics has started a Phase Ib/IIa clinical trial of its NDV-3 vaccine, which is being developed to prevent episodes of vulvovaginal candidiasis (VVC) in patients with recurrent VVC (RVVC). Under the trial, which is a ...
Tags: NDV-3 Vaccine, NovaDigm
US-based in vitro diagnostic company Venaxis announced that the Data and Safety Monitoring Board (DSMD) has recommended the continuation of pivotal clinical trial of the APPY1 test, a multiple biomarker-based assay for identifying patients ...
Tags: Appy1 Test, Clinical Trial
The US Patent & Trademark Office (USPTO) has issued a notice of allowance for Elorac's patent application regarding novel acne therapy. The US patent is entitled "Method and Composition for Treating Nodulocystic and Conglobate Acne ...
Tags: Acne Therapy, Medicine
The US Food and Drug Administration’s (FDA) Ophthalmic Devices Panel announced that Ocular Therapeutix’s ReSure sealant is safe and effective in managing clear corneal wound leaks following cataract surgery. ReSure Sealant is ...
Tags: Ocular Therapeutix, Medicine